Refsums Disease—Use of the Intestinal Lipase Inhibitor, Orlistat, as a Novel Therapeutic Approach to a Complex Disorder 外文参考文献.docVIP

下载本文档

4
0
约2.01万字
约 6页
2017-05-10 发布于上海
举报

Refsums Disease—Use of the Intestinal Lipase Inhibitor, Orlistat, as a Novel Therapeutic Approach to a Complex Disorder 外文参考文献.doc

Refsums Disease—Use of the Intestinal Lipase Inhibitor, Orlistat, as a Novel Therapeutic Approach to a Complex Disorder 外文参考文献

HindawiPublishingCorporation JournalofObesity Volume2011,ArticleID482021,5pages doi:10.1155/2011/482021 CaseReport Refsum’sDisease—UseoftheIntestinalLipaseInhibitor,Orlistat, asaNovelTherapeuticApproachtoaComplexDisorder NimalieJ.Perera, BarryLewis, HuyTran, 1 2 3MichaelFietz,4,5andDavidR.Sullivan1 1 2 3 4 DepartmentofClinicalBiochemistry,RoyalPrinceAlfredHospital,Sydney,Camperdown,NSW2050,Australia DepartmentofMedicine,UniversityofSydney,NSW2006,Australia DepartmentofBiochemistry,JohnHunterHospital,Newcastle,NSW2305,Australia NationalReferralLaboratoryforLysosomal,Pe

您可能关注的文档

文档评论（0）

1亿VIP精品文档

更多 >

Refsums Disease—Use of the Intestinal Lipase Inhibitor, Orlistat, as a Novel Therapeutic Approach to a Complex Disorder 外文参考文献.docVIP